Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 826 AL 840

Psychoactive substances: novel molecular insights and therapeutic potential for Alzheimer's disease

Fu C, Li X, Liu X, Zheng Y, Ma X, Zhang B, Chen S, Hu L, Su S, Wang X, Sun J, Yin Q, Wang Y, Fu X, Bao Y, Xue Y, Xin T, Lu L, Zou G.

Transl Neurodegener. 2025 Jul 25;14(1):38. doi: 10.1186/s40035-025-00498-1.

Exploring the Endoplasmic Reticulum's Role in Alzheimer's Disease and Its Potential as a Therapeutic Target

Saleh RO, Jabir MS, Mohammed JS, Ahmad I, Ganesan S, Shankhyan A, Nanda A, Ray S, Zwamel AH, Hussein AR.

J Biochem Mol Toxicol. 2025 Aug;39(8):e70405. doi: 10.1002/jbt.70405.

The Evolution of AChE Inhibitors in Alzheimer's Disease: From Single-Target to Multi-Target Ligands

Mehta NV, Kapadia A, Khambete M, Abhyankar A.

Chembiochem. 2025 Sep 15;26(17):e202500053. doi: 10.1002/cbic.202500053. Epub 2025 Jul 28.

Asperuloside as a promising multi-target agent for Alzheimer's disease: molecular mechanisms and therapeutic perspectives

Vashisht K, Kumar H, Ankalgi A, Ashawat MS, Rimpi, Kushawaha SK, Baldi A.

Inflammopharmacology. 2025 Aug;33(8):4311-4321. doi: 10.1007/s10787-025-01869-w. Epub 2025 Jul 28.

Intron Retention and Alzheimer's Disease (AD): A Review of Regulation Genes Implicated in AD

El-Seedy A, Ladevèze V.

Genes (Basel). 2025 Jun 30;16(7):782. doi: 10.3390/genes16070782.

The Therapeutic Potential of Butyrate and Lauric Acid in Modulating Glial and Neuronal Activity in Alzheimer's Disease

Senarath RMUS, Oikari LE, Bharadwaj P, Jayasena V, Martins RN, Fernando WMADB.

Nutrients. 2025 Jul 10;17(14):2286. doi: 10.3390/nu17142286.

The structural foundations of anti-amyloid-β immunotherapies: Unravelling antibody-antigen interactions in Alzheimer's disease treatment

Miles LA, Masters CL.

J Alzheimers Dis. 2025 Sep;107(2):393-408. doi: 10.1177/13872877251361049. Epub 2025 Sep 1.

Alzheimer's Disease: Treatment Challenges for the Future

Hardy J.

J Neurochem. 2025 Aug;169(8):e70176. doi: 10.1111/jnc.70176.

The sulfation pattern of glycosaminoglycans in human brain development and neurological disorders such as Alzheimer's disease

Hirano K, Egawa H, Nishihara S.

Am J Physiol Cell Physiol. 2025 Sep 1;329(3):C801-C811. doi: 10.1152/ajpcell.00842.2024. Epub 2025 Jul 31.

Application of Traditional Chinese Medicine in Alzheimer's Disease Treatment: A Focus on the Wnt/[Formula: see text]-Catenin Pathway

Ying C, He Y, Guo Y, Fan F, Wang B, Gao J, Li Y, Zhang Y.

Am J Chin Med. 2025;53(6):1641-1683. doi: 10.1142/S0192415X25500624. Epub 2025 Aug 1.

Resveratrol's Multifaceted Potential in Alzheimer's Disease: Insights from Preclinical and Clinical Evidence

Patel S, Thornton A, Parmar MS.

Mol Neurobiol. 2025 Dec;62(12):16229-16260. doi: 10.1007/s12035-025-05234-4. Epub 2025 Aug 1.

Mushrooms: Potential Agents for the Prevention and Slowdown of Alzheimer's Disease: A Review

Galić M, Ćilerdžić J, Stajic M.

Int J Med Mushrooms. 2025;27(10):7-19. doi: 10.1615/IntJMedMushrooms.2025059428.

Mechanisms and routes of G-protein coupled receptor-mediated Tau degradation in Alzheimer's disease

Ananthanarayana V, Chidamabram H, Govindaraj P, Vijayalakshmi K, Chinnathambi S.

Cytokine Growth Factor Rev. 2025 Oct;85:118-129. doi: 10.1016/j.cytogfr.2025.07.003. Epub 2025 Jul 18.

Beyond epilepsy: The expanding role of valproic acid in Alzheimer disease therapy - a review

Markowicz-Piasecka M, Miłkowska Z, Adla SK, Huttunen KM, Pietrzak B.

J Pharmacol Exp Ther. 2025 Sep;392(9):103658. doi: 10.1016/j.jpet.2025.103658. Epub 2025 Jul 10.

Diabetic retinopathy and Alzheimer's disease: Convergence of the unfolded protein response in neurodegeneration

Palacios AG, Zhang SX, Acosta ML.

Alzheimers Dement. 2025 Aug;21(8):e70497. doi: 10.1002/alz.70497.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias